Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Carteolol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB1 known ✓ | P08588 | 8/20 | 1.00 |
| ▸ | ADRB2 known ✓ | P07550 | 8/20 | 1.00 |
| ▸ | ADRB3 known ✓ | P13945 | 2/20 | 0.62 |
| ▸ | HTR1A | P08908 | 5/20 | 1.00 |
| ▸ | OPRK1 | P41145 | 1/20 | 1.00 |
| ▸ | SLC6A4 | P31645 | 3/20 | 0.62 |
| ▸ | TSHR | P16473 | 2/20 | 0.62 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.62 |
| ▸ | LMNA | P02545 | 2/20 | 0.55 |
| ▸ | MEN1 | O00255 | 2/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.55 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.55 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.55 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.55 |
| ▸ | RECQL | P46063 | 1/20 | 0.55 |
| ▸ | ADRA2A | P08913 | 3/20 | 0.52 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.52 |
| ▸ | MAOA | P21397 | 1/20 | 0.52 |
| ▸ | HTR2B | P41595 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 2/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Carteolol SCHEMBL24811 | 1.00 | ADRB1 (1.00) | ADRB1ADRB2HTR1AOPRK1SLC6A4 | |
| Carteolol SCHEMBL2549082 | 1.00 | ADRB1 (1.00) | ADRB1ADRB2HTR1AOPRK1SLC6A4 | |
| Carteolol SCHEMBL29908301 | 1.00 | ADRB1 (1.00) | ADRB1ADRB2HTR1AOPRK1SLC6A4 | |
| Carteolol SCHEMBL24810 | 1.00 | ADRB1 (1.00) | ADRB1ADRB2HTR1AOPRK1SLC6A4 | |
| Carteolol SCHEMBL30872857 | 1.00 | ADRB1 (1.00) | ADRB1ADRB2HTR1AOPRK1SLC6A4 | |
| Carteolol SCHEMBL41380 | 0.99 | ADRB2 (0.98) | ADRB1ADRB2HTR1AOPRK1SLC6A4 | |
| Carteolol SCHEMBL26664802 | 0.99 | ADRB1 (0.98) | ADRB1ADRB2HTR1AOPRK1SLC6A4 | |
| Carteolol SCHEMBL41382 | 0.99 | ADRB2 (0.98) | ADRB1ADRB2HTR1AOPRK1SLC6A4 | |
| Carteolol SCHEMBL29506901 | 0.99 | ADRB2 (0.98) | ADRB1ADRB2HTR1AOPRK1SLC6A4 | |
| Carteolol SCHEMBL26664799 | 0.99 | ADRB1 (0.98) | ADRB1ADRB2HTR1AOPRK1SLC6A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2229 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240033258-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF ADDICTION AND OTHER NEUROPSYCHIATRIC DISORDERS | BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY & AGRICULTURAL & MECHANICAL COLLEGE (US) | 2024-02-01 | — | — | US | claimed |
| US-20220333169-A1 | Polygenic Score for Cardiac Heart Failure | HENRY FORD HEALTH SYSTEM (US) | 2022-10-20 | — | — | US | claimed |
| WO-2021051033-A1 | POLYGENIC SCORE FOR CARDIAC HEART FAILURE | HENRY FORD HEALTH SYSTEM (US) | 2021-03-18 | — | — | WO | claimed |
| US-20200129528-A1 | METHODS FOR TREATING BLOOD PRESSURE CONDITIONS USING AMINOSTEROL COMPOSITIONS | ENTERIN, INC. | 2020-04-30 | — | — | US | claimed |
| EP-2054049-B1 | SUBSTITUTED ACYLANILIDES AND METHODS OF USE THEREOF | UNIV TENNESSEE RES FOUNDATION (US) | 2016-04-13 | — | — | EP | claimed |
| WO-2015077676-A1 | SERUM BIOMARKERS IN HUMAN KIDNEY DISEASE PATIENTS | SINGULEX, INC. (US) | 2015-05-28 | — | — | WO | claimed |
| WO-2014116708-A1 | ENDOTHELIN IN THE DIAGNOSIS OF CARDIAC DISEASE | SINGULEX, INC. (US) | 2014-07-31 | — | — | WO | claimed |
| US-20140206632-A1 | Endothelin in the Diagnosis of Cardiac Disease | SINGULEX, INC. (US) | 2014-07-24 | — | — | US | claimed |
| US-20140011774-A1 | SELECTIVE ANDROGEN RECEPTOR MODULATORS | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION | 2014-01-09 | — | — | US | claimed |
| EP-2478918-A2 | Compositions and methods for the treatment of addiction and other neuropsychiatric disorders | BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE (US) | 2012-07-25 | — | — | EP | claimed |
| WO-2008024456-A2 | SUBSTITUTED ACYLANILIDES AND METHODS OF USE THEREOF | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) | 2008-02-28 | — | — | WO | claimed |
| WO-2008008433-A2 | SUBSTITUTED ACYLANILIDES AND METHODS OF USE THEREOF | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) | 2008-01-17 | — | — | WO | claimed |
| US-20070281906-A1 | Selective androgen receptor modulators for treating diabetes | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION | 2007-12-06 | — | — | US | claimed |
| WO-2007056618-A9 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF ADDICTION AND OTHER NEUROPSYCHIATRIC DISORDERS | UNIV LOUISIANA STATE (US) | 2007-07-12 | — | — | WO | claimed |
| WO-2007056618-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF ADDICTION AND OTHER NEUROPSYCHIATRIC DISORDERS | BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY & AGRICULTURAL & MECHANICAL COLLEGE (US) | 2007-05-18 | — | — | WO | claimed |
| WO-2005097087-A2 | MERGED ION CHANNEL MODULATING COMPOUNDS AND USES THEREOF | CARDIOME PHARMA CORP. (CA) | 2005-10-20 | — | — | WO | claimed |
| EP-1555019-A1 | Pharmacologic drug combination in vagal-induced asystole | Emory University (US) | 2005-07-20 | — | — | EP | claimed |
| US-20040096501-A1 | Novel drug delivery system | TORRENT PHARMACEUTICALS LIMITED (IN) | 2004-05-20 | — | — | US | claimed |
| US-20020049155-A1 | Cobalamin compounds useful as cardiovascular agents and as imaging agents | HOGENKAMP HENRICUS P C (US) | 2002-04-25 | — | — | US | claimed |
| WO-2001092283-A2 | COBALAMIN COMPOUNDS USEFUL AS CARDIOVASCULAR AGENTS AND AS IMAGING AGENTS | MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) | 2001-12-06 | — | — | WO | claimed |